APAC Fluoroscopy Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.21 Billion |
| Market Size (2029) | USD 1.56 Billion |
| CAGR (2024 - 2029) | 5.11 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
APAC Fluoroscopy Market Analysis
The Asia-Pacific Fluoroscopy Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.56 billion by 2029, growing at a CAGR of 5.11% during the forecast period (2024-2029).
Fluoroscopy devices market is primarily driven by rising demand for minimally-invasive surgeries, growing geriatric population, the prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.
Medical imaging has applications at various stages of inpatient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role for imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses that are driven by minimally-invasive procedures. Fluoroscopy presents real-time moving images for the diagnostic evaluation of soft and hard tissue conditions. It is an indispensable tool for many interventional medical procedures. The fluoroscopy market is anticipated to register significant growth, with an increasing number of minimally-invasive surgeries that are of high-precision, including the devices used, resulting in better support for both patients and surgeons. In December 2017, Hologic Inc. introduced Fluoroscan InSight FD Mini C-Arm extremities imaging system at the 2017 Radiological Society of Asia-Pacific (RSNA) annual conference in Chicago. The advancemnets in the products and new roduct launches in teh region is also boosting the market. However, the side effects associated with radiation is expected to hinder the market growth over the forecast period.
APAC Fluoroscopy Market Trends
This section covers the major market trends shaping the APAC Fluoroscopy Market according to our research experts:
The Cardiovascular Segment, under Application, is Expected to Account for the Largest Market Share, during the Forecast Period
Cardiovascular procedures require extensive fluoroscopic guidance to navigate endovascular catheters. The fluoroscopy provides excellent spatial and temporal resolution, having a limitation of exposure of ionizing radiation to the patients and staff, along with poor soft tissue characterization. In the process of cardiac catheterization, fluoroscopy is used to help the healthcare provider see the flow of blood through the coronary arteries to check for arterial blockages. Therefore, the rising prevalence of cardiovascular diseases across the region is a major factor driving the growth of the market. According to self-reported data from the Australian Bureau of Statistics (ABS) 2017-18 National Health Survey, an estimated 1.2 million Australian adults aged 18 years and over had one or more conditions related to the heart or vascular disease, including stroke for the year 2017-2018. Thus, owing to the rising prevalence of cardiac diseases and benefits associated with fluoroscopy, the market is expected to grow over the forecast period.
APAC Fluoroscopy Industry Overview
The Asia-Pacific Fluoroscopy Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major players Merck KGaA, Thermo Fisher Scientific, GE Healthcare, Sovicell GMBH, Absorption Systems , Eurofins Scientific, ADMEcell, Inc.
APAC Fluoroscopy Market Leaders
-
Canon Medical Systems Corporation
-
GE Healthcare (GE Company)
-
Hitachi Medical Systems
-
Siemens Healthineers
-
Hologic Inc.
*Disclaimer: Major Players sorted in no particular order
APAC Fluoroscopy Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Geriatric Population and Prevalence of Chronic Diseases
- 4.2.2 Rising Demand for Minimally-invasive Surgeries
- 4.2.3 Increasing Use of Fluoroscopy in Pain Management
-
4.3 Market Restraints
- 4.3.1 Side Effects and Radiation Exposure
- 4.3.2 Rising Adoption of Refurbished Systems
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Device Type
- 5.1.1 Fixed Fluoroscopes
- 5.1.2 Mobile Fluoroscopes
- 5.1.2.1 Full-size Fluoroscopes
- 5.1.2.2 Mini Fluoroscopes
-
5.2 By Application
- 5.2.1 Orthopedic
- 5.2.2 Cardiovascular
- 5.2.3 Pain Management and Trauma
- 5.2.4 Neurology
- 5.2.5 Gastrointestinal
- 5.2.6 Urology
- 5.2.7 General Surgery
- 5.2.8 Other Applications
-
5.3 Geography
- 5.3.1 Asia-Pacific
- 5.3.1.1 China
- 5.3.1.2 Japan
- 5.3.1.3 India
- 5.3.1.4 Australia
- 5.3.1.5 South Korea
- 5.3.1.6 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Canon Medical Systems Corporation
- 6.1.2 GE Healthcare (GE Company)
- 6.1.3 Hitachi Medical Systems
- 6.1.4 Siemens Healthineers
- 6.1.5 Hologic Inc.
- 6.1.6 Orthoscan Inc.
- 6.1.7 Shimadzu Medical
- 6.1.8 Koninklijke Philips NV
- 6.1.9 Carestream Health
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAPAC Fluoroscopy Industry Segmentation
As per the scope of the report, fluoroscopy refers to an imaging technique that uses X-rays to produce real-time images of internal organs. Unlike X-ray images, which are fixed still images on film, the fluoroscopy produces live moving pictures of internal organs, which can be viewed by the naked eye on a digital monitor. This report is segmented by Device Type, Application and by Geography.
| By Device Type | Fixed Fluoroscopes | |
| Mobile Fluoroscopes | Full-size Fluoroscopes | |
| Mini Fluoroscopes | ||
| By Application | Orthopedic | |
| Cardiovascular | ||
| Pain Management and Trauma | ||
| Neurology | ||
| Gastrointestinal | ||
| Urology | ||
| General Surgery | ||
| Other Applications | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific |
APAC Fluoroscopy Market Research FAQs
How big is the Asia-Pacific Fluoroscopy Market?
The Asia-Pacific Fluoroscopy Market size is expected to reach USD 1.21 billion in 2024 and grow at a CAGR of 5.11% to reach USD 1.56 billion by 2029.
What is the current Asia-Pacific Fluoroscopy Market size?
In 2024, the Asia-Pacific Fluoroscopy Market size is expected to reach USD 1.21 billion.
Who are the key players in Asia-Pacific Fluoroscopy Market?
Canon Medical Systems Corporation, GE Healthcare (GE Company), Hitachi Medical Systems, Siemens Healthineers and Hologic Inc. are the major companies operating in the Asia-Pacific Fluoroscopy Market.
What years does this Asia-Pacific Fluoroscopy Market cover, and what was the market size in 2023?
In 2023, the Asia-Pacific Fluoroscopy Market size was estimated at USD 1.15 billion. The report covers the Asia-Pacific Fluoroscopy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Fluoroscopy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia-Pacific Fluoroscopy Industry Report
Statistics for the 2024 Asia-Pacific Fluoroscopy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Fluoroscopy analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
